Dupont Capital Management Corp Adverum Biotechnologies, Inc. Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021
SELL
$9.26 - $14.36 $224,462 - $348,086
-24,240 Closed
0 $0
Q4 2020

Jan 28, 2021
BUY
$9.84 - $14.26 $112,313 - $162,763
11,414 Added 88.99%
24,240 $263,000
Q3 2020

Oct 29, 2020
SELL
$10.3 - $21.64 $8,847 - $18,588
-859 Reduced 6.28%
12,826 $132,000
Q2 2020

Jul 24, 2020
BUY
$8.53 - $25.64 $116,733 - $350,883
13,685 New
13,685 $286,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email